Our Company Strategy & Mission Leadership Our Board Partnering Opportunities Out-Licensing Opportunities Contact Our Pipeline Clinical Trials Clinical Trials Compassionate Use Disease Information Innovation Engine Akeso Partnership Overview Ivonescimab (SMT112) Overview Therapeutic Areas News Center Media Resources Press Releases Investor Center Investor Center Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Career Opportunities
Press Releases Our latest press releases are available to read here Press Releases Date Range Explore Search Press Releases / 30 Mar 2010 Research Update Press Releases / 05 Mar 2010 Pre-close Dealings March SGD Press Releases / 05 Mar 2010 Pre-close Dealings Press Releases / 24 Feb 2010 Trading Update Press Releases / 12 Jan 2010 DMD Phase I Clinical Trial Start Press Releases / 30 Dec 2009 Result of General Meeting Press Releases / 30 Dec 2009 Result of Placing & Open Offer Press Releases / 11 Dec 2009 Wellcome Grant Award Press Releases / 11 Dec 2009 Placing & Open Offer Press Releases / 23 Oct 2009 Interim Results 2009 Press Releases / 21 Oct 2009 Notice of Interims Press Releases / 02 Sep 2009 Dextra Divestment << 1 2 … 30 31 32 >>
Press Releases / 30 Mar 2010 Research Update Press Releases / 05 Mar 2010 Pre-close Dealings March SGD Press Releases / 05 Mar 2010 Pre-close Dealings Press Releases / 24 Feb 2010 Trading Update Press Releases / 12 Jan 2010 DMD Phase I Clinical Trial Start Press Releases / 30 Dec 2009 Result of General Meeting Press Releases / 30 Dec 2009 Result of Placing & Open Offer Press Releases / 11 Dec 2009 Wellcome Grant Award Press Releases / 11 Dec 2009 Placing & Open Offer Press Releases / 23 Oct 2009 Interim Results 2009 Press Releases / 21 Oct 2009 Notice of Interims Press Releases / 02 Sep 2009 Dextra Divestment
Website Cookies This website uses cookies: Please see our Privacy Policy to understand how we use cookies. Okay, thanks